AskBorsa

SPINALEX results, Q2 2024

Net profit, assets, equity and cash flow for Q2 2024, against the same period a year earlier, from the published financial statements. fiscal year starts in July.

Net profit48.12 millionEGP · +279.6% vs the same period a year earlier
Total assets966 millionEGP · +38.4% vs the same period a year earlier
Shareholders' equity741 millionEGP · +20.9% vs the same period a year earlier
Operating cash flow-25.94 millionEGP · −1062.0% vs the same period a year earlier

In short

  • SPINALEX's net profit for Q2 2024 was about 48.12 million EGP, up +279.6% from 12.68 million EGP in Q2 2023.
  • Total assets at the end of Q2 2024 were about 966 million EGP, and shareholders' equity about 741 million EGP.
  • Operating cash flow for Q2 2024 was negative at 25.94 million EGP.
Source: the Q2 2024 financial statements

Key lines against the same period a year earlier

This periodQ2 2023Change
Net profit48.12 million12.68 million+279.6%
Gross profit30.15 million15.16 million+98.9%
Total assets966 million698 million+38.4%
Total liabilities225 million85.11 million+164.3%
Shareholders' equity741 million613 million+20.9%
Total liabilities and equity966 million698 million+38.4%
Operating cash flow-25.94 million2.7 million−1062.0%
Investing cash flow57.16 million4.8 million+1090.9%
Financing cash flow-27.85 million-3.9 million−614.9%
Net change in cash3.37 million3.6 million−6.4%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.

Official report (PDF)All of SPINALEX's statements, five yearsAsk the AI analyst about SPIN

SPINALEX's Fiscal year 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for SPINALEX